Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Galván, Jose A ^a   Astudillo, Aurora ^a,b   Vallina, Aitana ^a   Crespo, Guillermo ^c   Folgueras, Maria Victoria ^b   González, Maria Victoria ^a,d  

^a CajAstur Welfare Project   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

^d UNIVERSITY OF OVIEDO   (Spain)

Author keywords

E cadherin; Epithelial Mesenchymal transition; Foxc2; Pulmonary neuroendocrine tumors; Snail; catenin

Indexed keywords

BETA CATENIN; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SNAIL1; TRANSCRIPTION FACTOR SNAIL2; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG; UVOMORULIN; TUMOR MARKER;

ADULT; ADVERSE OUTCOME; ARTICLE; ATYPICAL CARCINOID; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOID; CLINICAL FEATURE; COHORT ANALYSIS; COMPLEX FORMATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG TUMOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PULMONARY NEUROENDOCRINE TUMOR; SMALL CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TISSUE MICROARRAY; TRANSBRONCHIAL BIOPSY; TRANSCRIPTION REGULATION; TYPICAL CARCINOID; AGED; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NEUROENDOCRINE TUMORS; PATHOLOGY; PROGNOSIS; RISK FACTOR; TUMOR VOLUME;

ADULT; AGED; BIOMARKERS, TUMOR; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PROGNOSIS; RISK FACTORS; TUMOR BURDEN;

EID: 84964314167     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-855     Document Type: Article

References (43)

1. Gustafsson BI, Kidd M, Chan A, Malfertheiner MV, Modlin IM: Bronchopulmonary neuroendocrine tumors. Cancer 2008, 113(1):5-21.
2. Marchevsky AM: Neuroendocrine tumors of the lung. Pathology (Phila) 1996, 4(1):103-123.
3. Rekhtman N: Neuroendocrine tumors of the lung: an update. Arch Pathol Lab Med 2010, 134(11):1628-1638.
4. Hage R, de la Riviere AB, Seldenrijk CA, van den Bosch JM: Update in pulmonary carcinoid tumors: a review article. Ann Surg Oncol 2003, 10(6):697-704.
5. http://seer.cancer.gov/: The US National Cancer Institute. Surveillance Epidemiology and End Results (SEER) data base, 1973-2004. In 2007.
6. Travis WDBE, Muller-Hermelink HK, Harris CC (Eds): WHO. Classification of Tumors. Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart. Lyon: IARC; 2004.
7. Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL: Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 2005, 307(5715):1603-1609.
8. Ikenouchi J, Matsuda M, Furuse M, Tsukita S: Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci 2003, 116(Pt 10):1959-1967.
9. Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674.
10. Thiery JP, Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006, 7(2):131-142.
11. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, Thompson EW: Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007, 213(2):374-383.
12. Takeichi M: The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development 1988, 102(4):639-655.
13. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, Garcia De Herreros A: The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000, 2(2):84-89.
14. Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, Cano A: The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 2003, 116(Pt 3):499-511.
15. Kang Y, Massague J: Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004, 118(3):277-279.
16. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117(7):927-939.
17. Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, Miura N, Kutok JL, Hartwell K, Richardson AL, Weinberg RA: Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci U S A 2007, 104(24):10069-10074.
18. Klymkowsky MW: beta-catenin and its regulatory network. Hum Pathol 2005, 36(3):225-227.
19. Maeda M, Johnson KR, Wheelock MJ: Cadherin switching: essential for behavioral but not morphological changes during an epithelium-tomesenchyme transition. J Cell Sci 2005, 118(Pt 5):873-887.
20. Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR: Cadherin switching. J Cell Sci 2008, 121(Pt 6):727-735.
21. Galván JA, Gonzalez MV, Crespo G, Folgueras MV, Astudillo A: Snail nuclear expression parallels higher malignancy potential in neuroendocrine lung tumors. Lung Cancer 2010, 69(3):289-295.
22. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM: Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 2005, 97(16):1180-1184.
23. Trimboli AJ, Fukino K, de Bruin A, Wei G, Shen L, Tanner SM, Creasap N, Rosol TJ, Robinson ML, Eng C, Ostrowski MC, Leone G: Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res 2008, 68(3):937-945.
24. Vergara D, Merlot B, Lucot JP, Collinet P, Vinatier D, Fournier I, Salzet M: Epithelial-mesenchymal transition in ovarian cancer. Cancer Lett 2010, 291(1):59-66.
25. Usami Y, Satake S, Nakayama F, Matsumoto M, Ohnuma K, Komori T, Semba S, Ito A, Yokozaki H: Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression. J Pathol 2008, 215(3):330-339.
26. Meng W, Takeichi M: Adherens junction: molecular architecture and regulation. Cold Spring Harb Perspect Biol 2009, 1(6):a002899.
27. Salon C, Moro D, Lantuejoul S, Brichon Py P, Drabkin H, Brambilla C, Brambilla E: E-cadherin-beta-catenin adhesion complex in neuroendocrine tumors of the lung: a suggested role upon local invasion and metastasis. Hum Pathol 2004, 35(9):1148-1155.
28. Pelosi G, Scarpa A, Puppa G, Veronesi G, Spaggiari L, Pasini F, Maisonneuve P, Iannucci A, Arrigoni G, Viale G: Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Cancer 2005, 103(6):1154-1164.
29. Ilyas M, Tomlinson IP: The interactions of APC, E-cadherin and beta-catenin in tumour development and progression. J Pathol 1997, 182(2):128-137.
30. van Es JH, Barker N, Clevers H: You Wnt some, you lose some: oncogenes in the Wnt signaling pathway. Curr Opin Genet Dev 2003, 13(1):28-33.
31. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA: The transcription factor snail controls epithelialmesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000, 2(2):76-83.
32. Kokkinos MI, Wafai R, Wong MK, Newgreen DF, Thompson EW, Waltham M: Vimentin and epithelial-mesenchymal transition in human breast cancer-observations in vitro and in vivo. Cells Tissues Organs 2007, 185(1-3):191-203.
33. Travis WD, Gal AA, Colby TV, Klimstra DS, Falk R, Koss MN: Reproducibility of neuroendocrine lung tumor classification. Hum Pathol 1998, 29(3):272-279.
34. Gheldof A, Berx G: Cadherins and Epithelial-to-Mesenchymal Transition. Prog Mol Biol Transl Sci 2013, 116:317-336.
35. Kaarteenaho R, Lappi-Blanco E, Lehtonen S: Epithelial N-cadherin and nuclear beta-catenin are up-regulated during early development of human lung. BMC Dev Biol 2010, 10:113.
36. Satomi K, Morishita Y, Sakashita S, Kondou Y, Furuya S, Minami Y, Noguchi M: Specific expression of ZO-1 and N-cadherin in rosette structures of various tumors: possible recapitulation of neural tube formation in embryogenesis and utility as a potentially novel immunohistochemical marker of rosette formation in pulmonary neuroendocrine tumors. Virchows Arch 2011, 459(4):399-407.
37. Zynger DL, Dimov ND, Ho LC, Laskin WB, Yeldandi AV: Differential expression of neural-cadherin in pulmonary epithelial tumours. Histopathology 2008, 52(3):348-354.
38. Utsuki S, Sato Y, Oka H, Tsuchiya B, Suzuki S, Fujii K: Relationship between the expression of E-, N-cadherins and beta-catenin and tumor grade in astrocytomas. J Neurooncol 2002, 57(3):187-192.
39. Vlahova L, Doerflinger Y, Houben R, Becker JC, Schrama D, Weiss C, Goebeler M, Helmbold P, Goerdt S, Peitsch WK: P-cadherin expression in Merkel cell carcinomas is associated with prolonged recurrence-free survival. Br J Dermatol 2012, 166(5):1043-1052.
40. Khorram-Manesh A, Ahlman H, Jansson S, Nilsson O: N-cadherin expression in adrenal tumors: upregulation in malignant pheochromocytoma and downregulation in adrenocortical carcinoma. Endocr Pathol 2002, 13(2):99-110.
41. Galvan JA, Astudillo A, Vallina A, Fonseca PJ, Gomez-Izquierdo L, Garcia-Carbonero R, Gonzalez MV: Epithelial-mesenchymal transition markers in the differential diagnosis of gastroenteropancreatic neuroendocrine tumors. Am J Clin Pathol 2013, 140(1):61-72.
42. Travis WD: Lung tumours with neuroendocrine differentiation. Eur J Cancer 2009, 45(Suppl 1):251-266.
43. Travis WD: Advances in neuroendocrine lung tumors. Ann Oncol 2010, 21(Suppl 7):vii65-vii71.